Optimizing haematopoietic stem and progenitor cell apheresis collection from plerixafor‐mobilized patients with sickle cell disease-Reference-Cited by-同舟云学术

Optimizing haematopoietic stem and progenitor cell apheresis collection from plerixafor‐mobilized patients with sickle cell disease

Published:2022-06-23 Issue:4 Volume:198 Page:740-744
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Sharma Akshay¹,Leonard Alexis²^ORCID,West Kamille³^ORCID,Gossett Jeffrey M.⁴,Uchida Naoya²,Panch Sandhya³,Stroncek David³,Poston Leigh⁵,Akel Salem⁵,Hankins Jane S.⁶^ORCID,Fitzhugh Courtney²,Hsieh Matthew M.²^ORCID,Kang Guolian⁴,Tisdale John F.²,Weiss Mitchell J.⁶,Zheng Yan⁷^ORCID

Affiliation:

1. Department of Bone Marrow Transplantation and Cellular Therapy St. Jude Children's Research Hospital Memphis Tennessee USA

2. Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute (NHLBI) National Institutes of Health Bethesda Maryland USA

3. Cell Processing Section, Department of Transfusion Medicine, Clinical Center National Institutes of Health Bethesda Maryland USA

4. Department of Biostatistics St. Jude Children's Research Hospital Memphis Tennessee USA

5. Human Applications Lab St. Jude Children's Research Hospital Memphis Tennessee USA

6. Department of Hematology St. Jude Children's Research Hospital Memphis Tennessee USA

7. Department of Pathology St. Jude Children's Research Hospital Memphis Tennessee USA

Funder

Doris Duke Charitable Foundation

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.18311

Reference14 articles.

1. Genetic therapies for the first molecular disease

2. Safe and efficient peripheral blood stem cell collection in patients with sickle cell disease using plerixafor

3. Successful hematopoietic stem cell mobilization and apheresis collection using plerixafor alone in sickle cell patients

4. Pathophysiology of Sickle Cell Disease

5. Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene therapies on the horizon for sickle cell disease: a clinician’s perspective;Expert Review of Hematology;2024-07-31

2. Development and IND-enabling studies of a novel Cas9 genome-edited autologous CD34+ cell therapy to induce fetal hemoglobin for sickle cell disease;Molecular Therapy;2024-07

3. Development and IND-enabling studies of a novel Cas9 genome-edited autologous CD34⁺cell therapy to induce fetal hemoglobin for sickle cell disease;2024-05-02

4. Hematopoietic stem cell collection for sickle cell disease gene therapy;Current Opinion in Hematology;2024-02-09

5. Collection of Hematopoietic Stem Cells and Cell Therapy Products;Comprehensive Hematology and Stem Cell Research;2024